Antidiabetic activity of extracts from needle, bark, and cone of Picea glauca: Organ-specific protection from glucose toxicity and glucose deprivation

Pharmaceutical Biology

Volumn 46, Issue 1-2, 2008, Pages 126-134

  Harris, Cory S ^a,b   Lambert, Jennifer ^a   Saleem, Ammar ^b   Coonishish, Jason ^c   Martineau, Louis C ^c   Cuerrier, Alain ^c   Haddad, Pierre S ^c   Arnason, John T ^b   Bennett, Steffany A L ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Glucose deprivation; Glucose toxicity; Natural health products; P. glauca; PC12 cells; Peripheral neuropathy; Plant extracts; Type 2 diabetes mellitus

Indexed keywords

PICEA GLAUCA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BARK; CELL CULTURE; CELL PROTECTION; CELL STRAIN; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; DRUG ACTIVITY; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MASS SPECTROMETRY; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIPHERAL NEUROPATHY; PLANT MORPHOLOGY; WHITE SPRUCE;

PICEA GLAUCA; PINACEAE;

EID: 38849121251     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200701735080     Document Type: Article

References (32)

1. Arnason JT, Hebda RJ, Johns T (1981): Use of plants for food and medicine by Native Peoples of Eastern Canada. Can J Bot 59: 2189-2235.
2. Black MJ (1980): Algonquin Ethnobotany: An Interpretation of Aboriginal Adaptation to Southwestern Quebec, Ottawa: National Museums of Canada, p. 266.
3. Boston P, Jordan S, MacNamara E, Kuzolanka K, Bobbish-Rondeau E, Iserhoff H, Mianscum S, Mianscum-Trapper R, Mitacheescik I, Petawabano B, Sheshamush-Masty M, Wapachee R, Weapenicappo J (1997): Using participatory action research to understand the meaning of aboriginal Canadians attributed to the rising incidence of diabetes. Chronic Diseases in Canada 18: 5-12.
4. Brewer C, Bonin F, Bullock B, Nault M-C, Morin J, Imbeault S, Shen TY, Franks DJ, Bennett SAL (2002): Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor. J Neurochem 18: 1502-1511.
5. Coskun O, Kanter M, Korkmaz A, Oter S (2005): Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol Res 51: 117-123.
6. Dajas F, Rivera F, Blasina F, Arredondo F, Echeverry C, Lafon L, Morquio A, Heizen H (2003): Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotox Res 5: 425-432.
7. Fridlyand LE, Philipson LH (2005): Oxidative reactive species in cell injury: Mechanisms in diabetes mellitus and therapeutic approaches. Ann NY Acad Sci 1066: 136-151.
8. Galli RL, Shukitt-Hale B, Youdim KA, Joseph JA (2002): Fruit polyphenolics and brain aging: Nutritional interventions targeting age-related neuronal and behavioral deficits. Ann NY Acad Sci 959: 128-132.
9. Harris CS, Burt AJ, Saleem A, Le PM, Martineau LC, Haddad PS, Bennett SA, Arnason JT (2007): A single HPLC-PAD-APCI/MS method for the quantitative comparison of phenolic compounds found in leaf, stem, root and fruit extracts of Vaccinium angustifolium. Phytochem Anal, 18: 161-169.
10. Hegele RA (2001): Genes, environment and diabetes in Canadian aboriginal communities. Adv Exp Med Biol, 498: 11-20.
11. Koshimura K, Tanaka J, Murakami Y, Kato Y (2002): Involvement of nitric oxide in glucose toxicity on differentiated PC12 cells: prevention of glucose toxicity by tetrahydrobiopterin, a cofactor for nitric oxide synthase. Neurosci Res, 43: 31-38.
12. Kuzmina E, Dannenebaum D (2004): Annual Update of the Cree Diabete Information System. Chisasibi, Quebec.
13. Leduc C, Coonishish J, Haddad P, Cuerrier A (2006): Plants used by the Cree Nation of Eeyou Istchee (Quebec, Canada) for the treatment of diabetes: A novel approach in quantitative ethnobotany. J Ethnopharmacol, 105: 55-63.
14. Légaré G (2004): Projet de surveillance du diabète chez les Cris d'Eeyou Istchee. Quebec, Institut National du Santé Publique du Québec et Conseil Cri de la Santé et des Serices Sociaux de la Baie-James.
15. Lieutier F, Brignolas F, Sauvard D, Yart A, Galet C, Brunet M, van de Sype H (2003): Intra- and inter-provenance variability in phloem phenols of Picea abies and relationship to a bark beetle-associated fungus. Tree Physiol 23: 247-256.
16. Martineau LC, Couture A, Spoor D, Benhaddou-Andaloussi A, Harris C, Meddah B, Leduc C, Burt A, Vuong T, Mai Le P, Prentki M, Bennett SA, Arnason JT, Haddad PS (2006): Anti-diabetic properties of the Canadian lowbush blueberry Vaccinium angustifolium Ait. Phytomedicine 13: 612-623.
17. McCune LM, Johns T (2002): Antioxidant activity in medicinal plants associated with the symptoms of diabetes mellitus used by the indigenous peoples of the North American boreal forest. J Ethnopharmacol 82: 197-205.
18. McCune LM, Johns T (2003): Symptom-specific antioxidant activity of boreal diabetes treatments. Pharm Biol 41: 362-379.
19. Moerman D (1998): Native American ethnobotany. Portland: Timber Press.
20. Pan H, Lundgren LN (1995): Phenolic extractives from root bark of Picea abies. Phytochemistry 39: 1423-1428.
21. Pollex RL, Hanley AJ, Zinman B, Harris SB, Khan HM, Hegele RA (2006): Metabolic syndrome in aboriginal Canadians: Prevalence and genetic associations. Atherosclerosis 184: 121-129.
22. Richardson MD, Peterson JR, Clark AM (1992): Bioactivity screenings of plants selected on the basis of folkloric use or presence of lignans in a family. Phytother Res 6: 274-278.
23. Ritch-Krc EM, Turner NJ, Tower GHN (1996): Carrier herbal medicine: an evaluation of the antimicrobial and anticancer activity in some frequently used remedies. J Ethnopharmacol 52: 151-156.
24. Rodriguez de Sotillo DV, Hadley M (2002): Chlorogenic acid modifies plasma and liver concentrations of cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem 13: 717-726.
25. Singleton VL, Rossi JA Jr (1965): Colorimetry of total phenolics with phosphomolbdic-phosphotungistic acid reagents. Am J Enol Vitic 16: 144-158.
26. Slimestad R (2003): Flavonoids in buds and young needles of Picea, Pinus, and Abies. Biochem System Ecol 31: 1247-1255.
27. Spoor DC, Martineau LC, Leduc C, Benhaddou-Andaloussi A, Meddah B, Harris C, Burt A, Fraser MH, Coonishish J, Joly E, Cuerrier A, Bennett SAL, Johns T, Prentki M, Arnason JT, Haddad PS (2006): Selected plant species from the Cree pharmacopoeia of northern Quebec possess anti-diabetic potential. Can J Physiol Pharmacol 84: 847-858.
28. Statistics Canada (2001): Population reporting an Aboriginal identity, by mother tongue, by province and territory (2001 Census). Available at http://www40statcanca/l01/cst01/demo38ahtm?sdi=cree. Accessed July 4, 2007.
29. Vogt A, Kalb EN, Lazo JS (2004): A scalable high-content cytotoxicity assay insensitive to changes in mitochondrial metabolic activity. Oncol Res 14: 305-314.
30. WHO (2004): Diabetes Action Now: An initiative of the World Health Organization and the International Diabetes Federation. Geneva, World Heath Organization. pp 1-20.
31. Young TK, Reading J, Elias B, O'Neil JD (2000): Type 2 diabetes mellitus in Canada's first nations: Status of an epidemic in progress. CMAJ 163: 561-566.
32. Yu CH, Zinman B (2007): Type 2 diabetes and impaired glucose tolerance in aboriginal populations: A global perspective. Diabetes Res Clin Pract. 78.